Jin Yang Pharmaceutical Co EBIT 2024

Jin Yang Pharmaceutical Co EBIT

9.09 B KRW

Jin Yang Pharmaceutical Co Dividend yield

2.85 %

Ticker

007370.KQ

ISIN

KR7007370000

In 2024, Jin Yang Pharmaceutical Co's EBIT was 9.09 B KRW, a -18.43% increase from the 11.14 B KRW EBIT recorded in the previous year.

The Jin Yang Pharmaceutical Co EBIT history

YEAREBIT (undefined KRW)
20239.09
202211.14
20216.96
20203.55
2019-0.22
20181.47
2017-5.29
2016-9.98
2015-1.06
20146.12
20134.88
20124.01
20110.37
20103.35
20098
20083.63
2007-1.31
20062.93
20056.18
20046.97

Jin Yang Pharmaceutical Co Aktienanalyse

What does Jin Yang Pharmaceutical Co do?

Jin Yang Pharmaceutical Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

EBIT Details

Analyzing Jin Yang Pharmaceutical Co's EBIT

Jin Yang Pharmaceutical Co's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Jin Yang Pharmaceutical Co's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Jin Yang Pharmaceutical Co's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Jin Yang Pharmaceutical Co’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Jin Yang Pharmaceutical Co Stock

How much did Jin Yang Pharmaceutical Co achieve in EBIT for the current year?

In the current year, Jin Yang Pharmaceutical Co has achieved an EBIT of 9.09 B KRW.

What is EBIT?

EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company Jin Yang Pharmaceutical Co.

How has the EBIT of Jin Yang Pharmaceutical Co developed in recent years?

The EBIT of Jin Yang Pharmaceutical Co has increased by -18.435% decreased compared to the previous year.

What does EBIT mean for investors?

EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.

Why is EBIT an important indicator for investors?

Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.

Why do EBIT values fluctuate?

EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.

What role does tax burden play in EBIT?

Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.

How is EBIT presented in the balance sheet of the company Jin Yang Pharmaceutical Co?

The EBIT of Jin Yang Pharmaceutical Co is listed in the income statement.

Can EBIT be used as a single indicator for evaluating a company?

EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.

Why is EBIT not equal to net profit?

The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.

How much dividend does Jin Yang Pharmaceutical Co pay?

Over the past 12 months, Jin Yang Pharmaceutical Co paid a dividend of 150 KRW . This corresponds to a dividend yield of about 2.85 %. For the coming 12 months, Jin Yang Pharmaceutical Co is expected to pay a dividend of 150 KRW.

What is the dividend yield of Jin Yang Pharmaceutical Co?

The current dividend yield of Jin Yang Pharmaceutical Co is 2.85 %.

When does Jin Yang Pharmaceutical Co pay dividends?

Jin Yang Pharmaceutical Co pays a quarterly dividend. This is distributed in the months of January, January, January, January.

How secure is the dividend of Jin Yang Pharmaceutical Co?

Jin Yang Pharmaceutical Co paid dividends every year for the past 20 years.

What is the dividend of Jin Yang Pharmaceutical Co?

For the upcoming 12 months, dividends amounting to 150 KRW are expected. This corresponds to a dividend yield of 2.85 %.

In which sector is Jin Yang Pharmaceutical Co located?

Jin Yang Pharmaceutical Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Jin Yang Pharmaceutical Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Jin Yang Pharmaceutical Co from 3/1/2024 amounting to 150 KRW, you needed to have the stock in your portfolio before the ex-date on 12/27/2023.

When did Jin Yang Pharmaceutical Co pay the last dividend?

The last dividend was paid out on 3/1/2024.

What was the dividend of Jin Yang Pharmaceutical Co in the year 2023?

In the year 2023, Jin Yang Pharmaceutical Co distributed 150 KRW as dividends.

In which currency does Jin Yang Pharmaceutical Co pay out the dividend?

The dividends of Jin Yang Pharmaceutical Co are distributed in KRW.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Jin Yang Pharmaceutical Co

Our stock analysis for Jin Yang Pharmaceutical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Jin Yang Pharmaceutical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.